Skip to main content
High RiskFDAfda-F-0680-2021UNDECLARED ALLERGEN

O'Brien's Own Gourmet Granola, busy bee's honey & oat, Net Wt. 12 OZ , UPC 6 09132 49667 7; Manufactured and Distributed by O'Brien's Own...

Units Affected
282
Recall Date
June 2, 2021
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0680-2021.

Three flavors of 3X Protein granola are labeled to contain whey, but do not declare milk on the label.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0680-2021.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Browns Granola Company, Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0680-2021.

Browns Granola Company, LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Browns Granola Company, Llc Recall FAQ

Browns Granola Company, Llc is the subject of a bakery & grains safety report: O'Brien's Own Gourmet Granola, busy bee's honey & oat, Net Wt. 12 OZ , UPC 6 09132 49667 7; Manufactured and Distributed by O'Brien's Own.... The notice was published on June 2, 2021 by the U.S. Food and Drug Administration (FDA). Approximately 282 units are potentially affected.